70 related articles for article (PubMed ID: 31673791)
1. Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma.
Jeon HL; Oh IS; Baek YH; Yang H; Park J; Hong S; Shin JY
J Bone Miner Metab; 2020 Mar; 38(2):254-263. PubMed ID: 31673791
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance).
Shapiro CL; Moriarty JP; Dusetzina S; Himelstein AL; Foster JC; Grubbs SS; Novotny PJ; Borah BJ
J Clin Oncol; 2017 Dec; 35(35):3949-3955. PubMed ID: 29023215
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India.
Wadhwa R; Gupta N; Dixit J; Malhotra P; Lakshmi P; Prinja S
JCO Glob Oncol; 2024 Mar; 10():e2300396. PubMed ID: 38452304
[TBL] [Abstract][Full Text] [Related]
4. Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer Than 2 Years With Metastatic Breast Cancer and Bone Metastasis.
Jayan A; Raghavendra AS; Bassett R; Barcenas CH
Clin Breast Cancer; 2023 Dec; 23(8):e515-e522. PubMed ID: 37735019
[TBL] [Abstract][Full Text] [Related]
5. Health resource utilization associated with skeletal-related events: results from a retrospective European study.
Body JJ; Pereira J; Sleeboom H; Maniadakis N; Terpos E; Acklin YP; Finek J; Gunther O; Hechmati G; Mossman T; Costa L; Rogowski W; Nahi H; von Moos R
Eur J Health Econ; 2016 Jul; 17(6):711-21. PubMed ID: 26253584
[TBL] [Abstract][Full Text] [Related]
6. Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland.
Lothgren M; Ribnicsek E; Schmidt L; Habacher W; Lundkvist J; Pfeil AM; Biteeva I; Vrouchou P; Bracco A
Eur J Hosp Pharm; 2013 Aug; 20(4):227-231. PubMed ID: 23888248
[TBL] [Abstract][Full Text] [Related]
7. Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.
Katakami N; Kunikane H; Takeda K; Takayama K; Sawa T; Saito H; Harada M; Yokota S; Ando K; Saito Y; Yokota I; Ohashi Y; Eguchi K
J Thorac Oncol; 2014 Feb; 9(2):231-8. PubMed ID: 24419421
[TBL] [Abstract][Full Text] [Related]
8. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study.
Santini D; Tampellini M; Vincenzi B; Ibrahim T; Ortega C; Virzi V; Silvestris N; Berardi R; Masini C; Calipari N; Ottaviani D; Catalano V; Badalamenti G; Giannicola R; Fabbri F; Venditti O; Fratto ME; Mazzara C; Latiano TP; Bertolini F; Petrelli F; Ottone A; Caroti C; Salvatore L; Falcone A; Giordani P; Addeo R; Aglietta M; Cascinu S; Barni S; Maiello E; Tonini G
Ann Oncol; 2012 Aug; 23(8):2072-2077. PubMed ID: 22219016
[TBL] [Abstract][Full Text] [Related]
9. Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis.
Hussain A; Aly A; Daniel Mullins C; Qian Y; Arellano J; Onukwugha E
Cancer Med; 2016 Nov; 5(11):3300-3309. PubMed ID: 27730756
[TBL] [Abstract][Full Text] [Related]
10. Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries.
von Moos R; Body JJ; Rider A; de Courcy J; Bhowmik D; Gatta F; Hechmati G; Qian Y
J Bone Oncol; 2018 Jun; 11():1-9. PubMed ID: 29892519
[TBL] [Abstract][Full Text] [Related]
11. Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone.
Onukwugha E; Kwok Y; Ciezki JP; Yong C; Plaisant C; Reddy CA; Mullins CD; Seal B; Valderrama A; Hussain A
PLoS One; 2017; 12(4):e0175956. PubMed ID: 28419139
[TBL] [Abstract][Full Text] [Related]
12. In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
Lund T; Gundesen MT; Juul Vangsted A; Helleberg C; Haukås E; Silkjær T; Asmussen JT; Manuela Teodorescu E; Amdi Jensen B; Schmidt Slørdahl T; Nahi H; Waage A; Abildgaard N; Schjesvold F;
Blood Cancer J; 2024 Apr; 14(1):65. PubMed ID: 38622134
[No Abstract] [Full Text] [Related]
13. Incidence of skeletal-related events in patients with Ewing sarcoma: An observational retrospective study in Japan.
Aiba H; Kojima Y; Shimoi T; Sudo K; Yazaki S; Imai T; Yoshida A; Iwata S; Kobayashi E; Kawai A; Arakawa A; Ogawa C; Kimura H; Yonemori K
Cancer Med; 2024 Mar; 13(5):e7060. PubMed ID: 38466026
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation.
Hahm ER; Kim SH; Pore SK; Mathan SV; Singh RP; Singh SV
Mol Carcinog; 2024 Feb; 63(2):301-313. PubMed ID: 37921547
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid in the management of metastatic bone disease.
Polascik TJ; Mouraviev V
Ther Clin Risk Manag; 2008 Feb; 4(1):261-8. PubMed ID: 18728715
[TBL] [Abstract][Full Text] [Related]
16. The role of vitamin E in the prevention of zoledronic acid-induced nephrotoxicity in rats: a light and electron microscopy study.
Sert İU; Kilic O; Akand M; Saglik L; Avunduk MC; Erdemli E
Arch Med Sci; 2018 Mar; 14(2):381-387. PubMed ID: 29593813
[TBL] [Abstract][Full Text] [Related]
17. The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer.
Demirtas D; Bilir C; Demirtas AO; Engin H
Clin Cases Miner Bone Metab; 2017; 14(1):35-39. PubMed ID: 28740523
[TBL] [Abstract][Full Text] [Related]
18. Liaison Treatment for Metastatic Spinal Tumors.
Nakanishi K; Uchino K; Watanabe S; Iba H; Hasegawa T
Spine Surg Relat Res; 2020; 4(3):223-228. PubMed ID: 32864488
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, Outcomes and Impact of Disease-Related Complications in the Survival of Multiple Myeloma Patients.
Tothong W; Tantiworawit A; Norasetthada L; Chai-Adisaksopha C; Punnachet T; Hantrakun N; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Rattarittamrong E
Hematol Rep; 2024 Feb; 16(1):89-97. PubMed ID: 38534879
[TBL] [Abstract][Full Text] [Related]
20. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
